Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid Derivative Dentifrice for Gingivitis
NCT02102295Phase 3Completed
- Sponsor
- Iovance Biotherapeutics
- Start
- Sep 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium ascorbyl phosphate in gingivitis (2 arms), sponsored by Iovance Biotherapeutics. Primary endpoint: Gingival Index at 3 months. Started Sep 2006; status: completed.
02
Drugs
magnesium ascorbyl phosphate
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT02102295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02102295.